Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
55.96
-0.23 (-0.41%)
Nov 13, 2024, 4:00 PM EST - Market closed
Cytokinetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 13, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6,604 | 8,186 | 4,336 | 3,823 | 1,471 | 628 | |
| Market Cap Growth | 119.67% | 88.80% | 13.41% | 159.95% | 134.31% | 81.53% | |
| Enterprise Value | 6,409 | 8,396 | 4,210 | 3,612 | 1,201 | 514 | |
| Last Close Price | 56.19 | 83.49 | 45.82 | 45.58 | 20.78 | 10.61 | |
| PS Ratio | 1929.92 | 1087.18 | 45.84 | 54.29 | 26.34 | 23.36 | |
| PB Ratio | -446.58 | -21.19 | -40.19 | 15.68 | 12.97 | -57.39 | |
| P/TBV Ratio | - | - | - | 15.68 | 12.97 | - | |
| P/OCF Ratio | - | - | - | - | 164.46 | - | |
| EV/Sales Ratio | 1991.04 | 1115.03 | 44.50 | 51.29 | 21.51 | 19.14 | |
| Debt / Equity Ratio | -56.76 | -1.96 | -6.95 | 1.11 | 1.23 | -12.44 | |
| Asset Turnover | 0.00 | 0.01 | 0.10 | 0.10 | 0.14 | 0.11 | |
| Quick Ratio | 9.22 | 6.00 | 9.25 | 7.35 | 15.10 | 8.85 | |
| Current Ratio | 9.28 | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 | |
| Return on Equity (ROE) | - | - | -572.15% | -120.54% | -248.50% | -1622.88% | |
| Return on Assets (ROA) | -30.13% | -33.73% | -21.83% | -16.94% | -14.26% | -24.67% | |
| Return on Capital (ROIC) | -60.40% | -61.23% | -35.05% | -30.40% | -31.11% | -63.62% | |
| Earnings Yield | -8.67% | -6.43% | -8.97% | -5.63% | -8.65% | -19.39% | |
| FCF Yield | -6.13% | -5.08% | -7.17% | -5.01% | -0.14% | -14.90% | |
| Buyback Yield / Dilution | -12.36% | -7.46% | -16.83% | -19.16% | -12.07% | -5.80% | |
| Total Shareholder Return | -12.36% | -7.46% | -16.83% | -19.16% | -12.07% | -5.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.